特兰胺酸的神经瘤应用:系统性审查和元分析
Mohammad Faizan Khan1, Saarang Patel2, Ryan Gensler3
1Department of Neurosurgery, Indiana University School of Medicine, Indianapolis, IN, USA.
概括
特兰胺酸 (TXA) 有效地减少了脑瘤手术中的血液损失,而不会增加风险. 它在脊髓瘤手术中的有效性需要进一步调查.
科学领域:
- 神经外科 神经外科
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 中枢神经系统 (CNS) 瘤带来了严重的血液损失的手术挑战.
- 抗纤维解质剂,如胺酸 (TXA),正在探索减轻手术出血.
- 与TXA使用相关的静脉血栓栓塞事件 (VTE) 的风险是一个关键考虑因素.
研究的目的:
- 审查关于TXA在减少中枢神经系统瘤切除过程中流失血液的疗效的证据.
- 在这个患者群体中评估TXA的安全性,特别是与VTE的相关性.
- 为了比较TXA的风险与异构血液输血的风险.
主要方法:
- 在三个数据库中进行了系统的文献搜索,寻找中枢神经系统瘤手术中TXA使用的研究.
- 提取的数据包括失血 (EBL/IOBL),手术持续时间,输血率和静脉瘤发病率.
- 分析比较了接受TXA和对照组的患者之间的结果.
主要成果:
- 在脑瘤切除过程中,TXA显著降低了血液损失,但没有增加静脉瘤或发作风险 (p < 0.001).
- 在脊髓瘤手术期间,TXA对手术内流血 (IOBL) 没有显著影响 (p = 0.66).
- 该分析包括16项符合条件的研究.
结论:
- TXA是一种安全有效的抗纤维解质剂,用于减少脑瘤手术中的血液损失.
- 在脊髓瘤切除中TXA的实用性需要进一步研究.
- 这一元分析提供了TXA在中枢神经系统瘤手术中的作用的全面概述.
相关概念视频
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K